{"2410.15198": {"publish_time": "2024-10-19", "title": "Medical-GAT: Cancer Document Classification Leveraging Graph-Based Residual Network for Scenarios with Limited Data", "paper_summary": "Accurate classification of cancer-related medical abstracts is crucial for\nhealthcare management and research. However, obtaining large, labeled datasets\nin the medical domain is challenging due to privacy concerns and the complexity\nof clinical data. This scarcity of annotated data impedes the development of\neffective machine learning models for cancer document classification. To\naddress this challenge, we present a curated dataset of 1,874 biomedical\nabstracts, categorized into thyroid cancer, colon cancer, lung cancer, and\ngeneric topics. Our research focuses on leveraging this dataset to improve\nclassification performance, particularly in data-scarce scenarios. We introduce\na Residual Graph Attention Network (R-GAT) with multiple graph attention layers\nthat capture the semantic information and structural relationships within\ncancer-related documents. Our R-GAT model is compared with various techniques,\nincluding transformer-based models such as Bidirectional Encoder\nRepresentations from Transformers (BERT), RoBERTa, and domain-specific models\nlike BioBERT and Bio+ClinicalBERT. We also evaluated deep learning models\n(CNNs, LSTMs) and traditional machine learning models (Logistic Regression,\nSVM). Additionally, we explore ensemble approaches that combine deep learning\nmodels to enhance classification. Various feature extraction methods are\nassessed, including Term Frequency-Inverse Document Frequency (TF-IDF) with\nunigrams and bigrams, Word2Vec, and tokenizers from BERT and RoBERTa. The R-GAT\nmodel outperforms other techniques, achieving precision, recall, and F1 scores\nof 0.99, 0.97, and 0.98 for thyroid cancer; 0.96, 0.94, and 0.95 for colon\ncancer; 0.96, 0.99, and 0.97 for lung cancer; and 0.95, 0.96, and 0.95 for\ngeneric topics.", "paper_summary_zh": "\u6e96\u78ba\u5206\u985e\u8207\u764c\u75c7\u76f8\u95dc\u7684\u91ab\u5b78\u6458\u8981\u5c0d\u65bc\u91ab\u7642\u4fdd\u5065\u7ba1\u7406\u548c\u7814\u7a76\u81f3\u95dc\u91cd\u8981\u3002\u7136\u800c\uff0c\u7531\u65bc\u96b1\u79c1\u554f\u984c\u548c\u81e8\u5e8a\u6578\u64da\u7684\u8907\u96dc\u6027\uff0c\u5728\u91ab\u7642\u9818\u57df\u4e2d\u53d6\u5f97\u6a19\u8a18\u5927\u578b\u6578\u64da\u96c6\u5177\u6709\u6311\u6230\u6027\u3002\u9019\u7a2e\u8a3b\u89e3\u6578\u64da\u7684\u7a00\u7f3a\u963b\u7919\u4e86\u958b\u767c\u7528\u65bc\u764c\u75c7\u6587\u4ef6\u5206\u985e\u7684\u6709\u6548\u6a5f\u5668\u5b78\u7fd2\u6a21\u578b\u3002\u70ba\u4e86\u61c9\u5c0d\u9019\u4e00\u6311\u6230\uff0c\u6211\u5011\u63d0\u4f9b\u4e86\u4e00\u500b\u7531 1,874 \u7bc7\u751f\u7269\u91ab\u5b78\u6458\u8981\u7d44\u6210\u7684\u7cbe\u9078\u6578\u64da\u96c6\uff0c\u5206\u985e\u70ba\u7532\u72c0\u817a\u764c\u3001\u7d50\u8178\u764c\u3001\u80ba\u764c\u548c\u4e00\u822c\u4e3b\u984c\u3002\u6211\u5011\u7684\u7814\u7a76\u91cd\u9ede\u5728\u65bc\u5229\u7528\u6b64\u6578\u64da\u96c6\u4f86\u6539\u5584\u5206\u985e\u6548\u80fd\uff0c\u7279\u5225\u662f\u5728\u8cc7\u6599\u7a00\u5c11\u7684\u60c5\u6cc1\u4e0b\u3002\u6211\u5011\u5f15\u5165\u4e86\u5177\u6709\u591a\u500b\u5716\u5f62\u6ce8\u610f\u5c64\u7684\u6b98\u5dee\u5716\u5f62\u6ce8\u610f\u7db2\u8def (R-GAT)\uff0c\u5b83\u53ef\u4ee5\u64f7\u53d6\u764c\u75c7\u76f8\u95dc\u6587\u4ef6\u4e2d\u7684\u8a9e\u7fa9\u8cc7\u8a0a\u548c\u7d50\u69cb\u95dc\u4fc2\u3002\u6211\u5011\u7684 R-GAT \u6a21\u578b\u8207\u5404\u7a2e\u6280\u8853\u9032\u884c\u6bd4\u8f03\uff0c\u5305\u62ec\u57fa\u65bc\u8f49\u63db\u5668\u7684\u6a21\u578b\uff0c\u4f8b\u5982\u4f86\u81ea\u8f49\u63db\u5668\u7684\u96d9\u5411\u7de8\u78bc\u5668\u8868\u793a (BERT)\u3001RoBERTa \u548c\u7279\u5b9a\u9818\u57df\u7684\u6a21\u578b\uff0c\u4f8b\u5982 BioBERT \u548c Bio+ClinicalBERT\u3002\u6211\u5011\u9084\u8a55\u4f30\u4e86\u6df1\u5ea6\u5b78\u7fd2\u6a21\u578b (CNN\u3001LSTM) \u548c\u50b3\u7d71\u6a5f\u5668\u5b78\u7fd2\u6a21\u578b (\u908f\u8f2f\u8ff4\u6b78\u3001SVM)\u3002\u6b64\u5916\uff0c\u6211\u5011\u63a2\u7d22\u4e86\u7d50\u5408\u6df1\u5ea6\u5b78\u7fd2\u6a21\u578b\u4ee5\u589e\u5f37\u5206\u985e\u7684\u6574\u9ad4\u65b9\u6cd5\u3002\u8a55\u4f30\u4e86\u5404\u7a2e\u7279\u5fb5\u63d0\u53d6\u65b9\u6cd5\uff0c\u5305\u62ec\u5177\u6709\u55ae\u5b57\u548c\u96d9\u5b57\u7684\u8a5e\u983b-\u9006\u6587\u4ef6\u983b\u7387 (TF-IDF)\u3001Word2Vec\uff0c\u4ee5\u53ca\u4f86\u81ea BERT \u548c RoBERTa \u7684\u6a19\u8a18\u5668\u3002R-GAT \u6a21\u578b\u512a\u65bc\u5176\u4ed6\u6280\u8853\uff0c\u5c0d\u65bc\u7532\u72c0\u817a\u764c\uff0c\u5be6\u73fe\u4e86 0.99\u30010.97 \u548c 0.98 \u7684\u6e96\u78ba\u5ea6\u3001\u53ec\u56de\u7387\u548c F1 \u5206\u6578\uff1b\u5c0d\u65bc\u7d50\u8178\u764c\uff0c\u5be6\u73fe\u4e86 0.96\u30010.94 \u548c 0.95\uff1b\u5c0d\u65bc\u80ba\u764c\uff0c\u5be6\u73fe\u4e86 0.96\u30010.99 \u548c 0.97\uff1b\u5c0d\u65bc\u4e00\u822c\u4e3b\u984c\uff0c\u5be6\u73fe\u4e86 0.95\u30010.96 \u548c 0.95\u3002", "author": "Elias Hossain et.al.", "authors": "Elias Hossain, Tasfia Nuzhat, Shamsul Masum, Shahram Rahimi, Sudip Mittal, Noorbakhsh Amiri Golilarz", "id": "2410.15198v2", "paper_url": "http://arxiv.org/abs/2410.15198v2", "repo": "null"}}